Ispire's Q3 earnings report reveals massive growth

May.17.2023
Ispire's Q3 earnings report reveals massive growth
Ispire released Q3 2023 financial report with impressive YoY revenue growth of 26.9% and gross profit growth of 51.9%.

On May 16th, Ispire announced the release of their financial report for the third quarter of 2023, ending on March 31st. The company also submitted their 10-Q quarterly report to the US Securities and Exchange Commission (SEC) on May 15th. According to the report, Ispire saw a year-over-year revenue growth of 26.9%, reaching $24.1 million in the third quarter, while their gross profit increased by 51.9% to $4.5 million.


It's worth noting that the company's fiscal year end is on June 30, 2023, and they have not chosen December 31 as their fiscal year end date.


Rise in Cannabis Smoking Accessories Sales is a Popular Betting Trend


Michael Wang, the Chief Financial Officer of Ispire, has stated that the company is expecting a continuous revenue growth of 58% to 98% in the fourth quarter of their marijuana smoking devices products.


He added:


We are focused on a multi-pronged strategy aimed at increasing sales of our electronic cigarette products and developing CBD vaporization products with an emphasis on medical and recreational use.


Third Quarter Performance: Tobacco vaporization remains the main product.


In the third quarter of 2023, Ispire recorded a year-on-year revenue growth of 26.9%, reaching $24.1 million. The revenue contribution of electronic cigarette products was $16.5 million, while that of CBD-related vaporizer products was $7.6 million. Gross profit grew 51.9% year-on-year to $4.5 million. However, total operating expenses increased by 106.2% YoY, reaching $8 million compared to $3.9 million in the same period of 2022. Net loss amounted to $3.1 million, whereas in the same period of 2022, the net loss was $1 million.


Looking ahead to the future.


Ispire has provided a projection for its CBD vaporization products for the fourth quarter of 2023 (ending June 30, 2023). The company began marketing CBD vaporization products in mid-2020, with revenue reaching $7.6 million in the third quarter of 2023. It is expected that the revenue in the fourth quarter of 2023 for CBD vaporization products will increase by 58% to 98% compared to the third quarter, with projected revenue ranging between $12 million to $15 million.


According to reports, Ispire is a company that specializes in research and development, design, commercialization, sales, promotion, and distribution of branded electronic cigarettes and CBD vaporization products. The company's tobacco electronic cigarette products are sold under the Aspire brand name.


References:


Ispire Technology Inc. has released its financial results for the third quarter of 2023.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

EU plans first-ever evaluation of health impacts of e-cigarettes and nicotine products in tobacco directive revision
EU plans first-ever evaluation of health impacts of e-cigarettes and nicotine products in tobacco directive revision
EU to assess health impact of e-cigarettes and nicotine-containing products for the first time during tobacco directive revision.
Sep.22 by 2FIRSTS.ai
New Zealand medical research: E-cigarettes have become a normalized tool among Māori youth, and scholars are calling for restrictions on device design
New Zealand medical research: E-cigarettes have become a normalized tool among Māori youth, and scholars are calling for restrictions on device design
Dr. Robin Quigg from the University of Otago in New Zealand conducted a study on e-cigarette use among young Māori people and found that more than half of the participants aged 18 to 26 had used e-cigarettes despite having no history of smoking. Due to the small size and discreet smell of e-cigarettes, combined with the addictive nature of nicotine, their use has become normalized in public places and the usage rate among young Māori people is on the rise. Dr. Quigg called for stricter regulatio
Aug.28 by 2FIRSTS.ai
Alan Zhao of 2Firsts: Combustibles Still Hold Strategic Value — JTI Offers New Insight into Global Tobacco Transition
Alan Zhao of 2Firsts: Combustibles Still Hold Strategic Value — JTI Offers New Insight into Global Tobacco Transition
As reduced-risk products emerge as the industry’s inevitable future, the question of how to transition has become a defining challenge for tobacco companies. In recent years, JTI has continued to invest in the combustible segment while gradually advancing its next-generation products — a path distinct from that of PMI and BAT, yet one that offers valuable insights for other legacy tobacco companies around the world.
Sep.29
Ukraine Busts Illegal E-Liquid Production Site, Seizing Over 5 Tons of Finished Product and Inputs
Ukraine Busts Illegal E-Liquid Production Site, Seizing Over 5 Tons of Finished Product and Inputs
Ukraine’s Bureau of Economic Security (BEB) dismantled an illegal e-liquid production site in Dnipropetrovsk Oblast, seizing more than five tons of liquids and related equipment. Two residents of Kryvyi Rih were notified of suspicion for “illegal manufacture, storage, transportation, and sale of excisable goods committed by a group upon prior conspiracy.” The case is being advanced jointly by the National Police and the Office of the Prosecutor General.
Sep.03 by 2FIRSTS.ai
Inter Tabac 2025: 2Firsts Provides Exclusive Coverage of New Tobacco Products and Industry Trends
Inter Tabac 2025: 2Firsts Provides Exclusive Coverage of New Tobacco Products and Industry Trends
2Firsts provides exclusive coverage of Inter Tabac 2025, capturing new tobacco products and industry trends for readers.
Sep.18 by 2FIRSTS.ai
JUUL Labs Accuses NJOY and Altria of Patent Infringement; U.S. ITC Launches Section 337 Investigation
JUUL Labs Accuses NJOY and Altria of Patent Infringement; U.S. ITC Launches Section 337 Investigation
The U.S. International Trade Commission (USITC) has instituted an investigation titled Certain Vaporizer Devices, Cartridges Used Therewith, and Components Thereof (II) based on a complaint by JUUL Labs, Inc. JUUL alleges that NJOY, its parent and affiliates at Altria Group, infringed U.S. Patent No. 12,156,533 through the importation and sale of certain ENDS devices, cartridges, and components. JUUL seeks a limited exclusion order and cease-and-desist orders. Respondents must answer within 20 d
Sep.11 by 2FIRSTS.ai